Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Felice Gragnano: Personalizing Antiplatelet Therapy After PCI
Nov 19, 2026, 13:18

Felice Gragnano: Personalizing Antiplatelet Therapy After PCI

Felice Gragnano, Associate Professor and Cardiologist at Università Vanvitelli, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Journal of Clinical Medicine, adding:

“Thrilled to share our latest review article published in Journal of Clinical Medicine (JCM) MDPI

‘Antiplatelet Modulation Strategies After PCI in Patients Without an Indication for Oral Anticoagulation’.

As ischemic and bleeding risks evolve over time after PCI, antiplatelet therapy should evolve with them. In this comprehensive review, we explore:

  • Antiplatelet de-escalation strategies
  • P2Y12 inhibitor monotherapy
  • Guided and unguided switching strategies
  • Antiplatelet escalation in patients at increased ischemic risk
  • Latest RCTs and implications for clinical practice.

The key message: moving toward dynamic, risk-adapted, and personalized antiplatelet therapy.

A sincere thank you to all colleagues and international experts who contributed to this collaborative work, and special thanks to Prof. Paolo Calabrò for his leadership, guidance, and continued support.”

Title: Antiplatelet Modulation Strategies After PCI in Patients Without an Indication for Oral Anticoagulation

Authors: Felice Gragnano, Vincenzo De Sio, Antonio Capolongo, Giuseppe Verde, Giovanni Pio Iannotti, Angelo Romano, Elio Mattia Migliaccio, Michelangelo Luciani, Gabriele Cappiello, Elisabetta Moscarella, Simona Sperlongano, Vincenzo Acerbo, Arturo Cesaro, Dobromir Dobrev, Antonio Landi, Diana A. Gorog, Dominick J. Angiolillo, Marco Valgimigli, Paolo Calabrò

Felice Gragnano: Personalizing Antiplatelet Therapy After PCI

Stay updated with Hemostasis Today.